Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Descriptive analysis of seizures and comorbidities associated with fragile X syndrome.
Implementation of a markerless motion analysis method to quantify hyperkinesis in males with fragile X syndrome.
Lymphocytic Extracellular Signal-Regulated Kinase Dysregulation in Autism Spectrum Disorder.
The Future of Fragile X Syndrome: CDC Stakeholder Meeting Summary.
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome.
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome. Brain Sci. 2020 Nov 24; 10(12).
View in:
PubMed
authors with profiles
Elizabeth M Berry-Kravis